Loading data
IBIONasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 100 k USD | 400 k USD | 225 k USD | — | 1.88 m USD |
| Research and development expense | 19.64 m USD | 8.31 m USD | 5.19 m USD | 10.33 m USD | 9.83 m USD |
| Operating profit | -35.14 m USD | -18.6 m USD | -16.63 m USD | -29.34 m USD | -29.7 m USD |
| Interest expense | — | — | — | 83 k USD | — |
| Profit before tax | -33.04 m USD | -18.38 m USD | — | — | — |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -32.84 m USD | -18.38 m USD | -24.91 m USD | -65.01 m USD | -50.3 m USD |
| Net income attributable to common shareholders | -33.04 m USD | -18.38 m USD | — | -29.31 m USD | -29.6 m USD |
| Basic earnings per share | -0.32 USD/share | -1.75 USD/share | -6.5 USD/share | -106.19 USD/share | -5.78 USD/share |
| Diluted earnings per share | -0.32 USD/share | -1.75 USD/share | -6.5 USD/share | -106.19 USD/share | -5.78 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.